Form 4 for CYTK CYTOKINETICS INC
Accepted 2025-10-27 00:00:00 ET · period of report 2025-10-27 · accession 0001061983-25-000026 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-10-27 | 2025-10-27 | CYTK | WIERENGA WENDELL | Dir | S - Sale+OE | $58.68 | -4,375 | 32.4K | -12% | -$256.7K |
| D | 2025-10-27 | 2025-10-27 | CYTK | WIERENGA WENDELL | Dir | M - OptEx | $10.00 | +4,375 | 36.8K | +13% | +$43.8K |
| D | 2025-10-27 | 2025-10-27 | CYTK | WIERENGA WENDELL | Dir | M - OptEx | $0.00 | -4,375 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-27 | S | D | 4,375 | $58.68 | 32,444 | D | — | — | |
| 2 | Common | Common Stock | 2025-10-27 | M | A | 4,375 | $10.00 | 36,819 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2025-10-27 | M | D | 4,375 | $0.00 | 0 | D | $10.00 · 2016-02-04 to 2026-01-04 | 4,375 Common Stock | (F1) This option shall vest and become exercisable as to 4,375 shares divided into equal monthly installments such that the option shall be 100% vested on January 4, 2017. |